This bill aims to boost research into rare cancers by requiring a regulatory review, appointing a specialist lead, and allowing NHS data to be used to contact patients for clinical trials.
A Bill to make provision to incentivise research and investment into the treatment of rare types of cancer; and for connected purposes.
Status: Act of Parliament
Current House: Unassigned
Stage: Royal Assent
Sponsored by: Dr Scott Arthur, Julie Elliott
Introduced: 2024-10-16
Royal Assent: 2026-03-05